KMT2A and acute myeloid leukemia: In all AML cell lines, these differentiation antigens were modulated over time, irrespectively of MLL-r and treatment responsiveness, with a statistically significant increase of at least one surface marker in most of the treated AML cell lines in comparison to untreated control cells (Figure 2C and Figure S1).